Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.61 USD | +0.53% | +16.46% | +28.74% |
Feb. 27 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.33M | Capitalization | 724M |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -232M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 546 x |
P/E ratio 2024 * |
-3.78
x | P/E ratio 2025 * |
-3.8
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.68% |
Latest transcript on Cogent Biosciences, Inc.
1 day | +0.53% | ||
1 week | +12.82% | ||
Current month | +16.46% | ||
1 month | +12.82% | ||
3 months | +25.54% | ||
6 months | -9.34% | ||
Current year | +28.74% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 20-10-22 |
John Green
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 19-07-25 |
Matthew Ros
BRD | Director/Board Member | 57 | 19-07-25 |
Todd Shegog
BRD | Director/Board Member | 59 | 21-02-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 237 M€ | +3.55% | - | |
0.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 7.56 | -0.13% | 230 374 |
24-05-06 | 7.57 | +0.53% | 1,079,833 |
24-05-03 | 7.53 | +3.29% | 846,306 |
24-05-02 | 7.29 | +5.19% | 1,157,205 |
24-05-01 | 6.93 | +6.62% | 2,649,834 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.74% | 724M | |
+9.15% | 106B | |
-1.08% | 104B | |
+6.99% | 23.25B | |
-11.55% | 22.5B | |
-7.26% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- COGT Stock